Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Capital Expenditures Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Capital Expenditures
-â‚ą3.4B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Capital Expenditures
-â‚ą27.4B
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Capital Expenditures
-â‚ą15.5B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Capital Expenditures
-â‚ą19.4B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Capital Expenditures
-â‚ą4.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Capital Expenditures
-â‚ą3.9B
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Capital Expenditures?
Capital Expenditures
-3.4B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Capital Expenditures amounts to -3.4B INR.

What is Natco Pharma Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-10%

Over the last year, the Capital Expenditures growth was -132%. The average annual Capital Expenditures growth rates for Natco Pharma Ltd have been -10% over the past three years .

Back to Top